We are an international health research institute based in Dhaka, Bangladesh.
Our research is addressing some of the world’s most pressing health challenges.
We aim to ensure that our evidence and experience is widely shared.
Stay up to date with our research and activities.
Our scientists and research outcomes are consistently featured by leading international media outlets, as illustrated by the stories below.
Please note that links are subject to the publisher’s archiving policy.
Showing 41 - 60 of 151
The study – the first of its kind to combine genome sequencing and mobile phone data – has found a direct link between mass migration from Dhaka, the capital of Bangladesh (an area of high infection), and the spread of coronavirus to the rest of the country after a stay-at-home order was announced during the nation’s first wave of infection in March 2020.
The study, conducted by the Stop TB Partnership and health research institute icddr,b, compared chest X-ray readings made by three certified radiologists in Dhaka with those done by five AI algorithms. The readings were then measured against the results of patients’ nucleic acid amplification tests, which were employed as the reference standard for TB diagnosis.
Firdausi Qadri, 70, was one of five recipients of the Ramon Magsaysay Award -- named after a Filipino president killed in a plane crash -- for her "life-long devotion to the scientific profession" and "untiring contributions to vaccine development".
Resistance to antibiotics is common and often deadly among children with pneumonia in Bangladesh, according to a new study coauthored by researchers from Massachusetts General Hospital (MGH) with colleagues at the International Centre for Diarrhoeal Disease Research, Bangladesh (abbreviated as icddr,b). This study, which appears in the journal Open Forum Infectious Diseases, offers an early warning that a pandemic of potentially deadly antibiotic resistance is under way and could spread around the globe.
One of the world’s leading global health research institutes, the International Centre for Diarrhoel Disease Research, Bangladesh, known as icddr,b, based in Dhaka, has collaborated on the project by helping to line up 1,500 people to participate in the trial. The app was developed in Bangla, the native language of the region.
In recent weeks, the medical team at the UNICEF/icddr,b SARI ITC has been observing a decreasing number of patients seeking care in their dedicated isolation facility.
“There is big demand for the Chinese vaccines,” says Firdausi Qadri, an immunologist at the International Centre for Diarrhoeal Disease Research, Bangladesh, in Dhaka.
Friendly gut bacteria have emerged as an invaluable ally in the war against malnutrition after a research study in Bangladesh showed that bacteria-targeting food supplements were more effective than standard nutritional supplements in improving the health of undernourished children.
icddr,b observed a dramatic change in the distribution of SARS-CoV-2 variants when the South African variant appeared. It became the most prevalent variant during the third week of March 2021 by replacing other variants. Most remarkably, the South African variant occupied 81% of the variants in the fourth week of March 2021. Our findings warrant continuous monitoring of genetic variations of SARS-CoV-2, which is crucial for vaccine effectiveness and patients management.
To save a starving child, aid workers have long used one obvious treatment: food. But a new study suggests feeding their gut bacteria may be as important—or even more important—than feeding their stomachs. In a head-to-head comparison against a leading treatment for malnutrition, a new supplement designed to promote helpful gut bacteria led to signs of improved growth and more weight gain, despite having 20% fewer calories. The study also highlights how important gut bacteria—the so-called microbiome—can be to human health.
We continue our “World Tour” of treatments for COVID-19, with this Debriefing interview with Professor Wasif Ali Khan, in Bangladesh.
The B.1.1.7 variant of SARS-CoV-2, the UK variant, has been detected for the first time in a Bangladeshi resident. The research is published in Microbiology Resource Announcements, a journal of the American Society for Microbiology.
As vaccination programmes in the developing world lag behind richer nations' efforts, a drug called ivermectin, commonly used for treating skin conditions and parasites in livestock, has shown some promise.
A systematic review and meta-analysis of international COVID-19 literature, led by UNSW Sydney, has confirmed that while children under five years old were likely to recover from the infection, half of those infected were infants and almost half of the infected under-fives were asymptomatic.
A "Be the Hero: Be the Change" blog about inspirational people who have stepped up to help
Patients who took only invermectin for 5 days 77% more likely to have early viral clearance after 14 days, says new study
icddr,b's Senior Scientist Dr Firdausi Qadri gave an exclusive interview to BBC World Service's The Real Story on COVID-19 vaccines.
In 2011, Dr. Qadri and her team at the International Centre for Diarrheal Disease and Research, Bangladesh (icddr,b) led a feasibility study on a newer, more affordable oral cholera vaccine, Shanchol.
Tufts University will lead a $100 million, five-year program to understand and address threats posed by zoonotic viral diseases that can "spill over" from animals to humans, such as SARS-CoV-2, in an effort to reduce risk of infection, amplification, and spread, the United States Agency for International Development (USAID) announced today.
Bangladesh has approved a late-stage trial of a potential COVID-19 vaccine developed by China's Sinovac Biotech Ltd in the hope of being a priority recipient for the jab, the health minister said on Thursday.